<DOC>
	<DOCNO>NCT02749162</DOCNO>
	<brief_summary>The effect perineural dexamethasone administer adjuvant prolonging duration analgesia continue debate . The investigator perform prospective randomize study evaluate effect perineural dexamethasone different concentration postoperative analgesia femoral nerve block anterior cruciate ligament reconstruction .</brief_summary>
	<brief_title>Perineural Dexamethasone Femural Nerve Block After Ligament Reconstruction</brief_title>
	<detailed_description>After Ethics committee approval , 75 patient American Society Anesthesiologists score ( ASA ) I-III randomized end surgery 3 group 25 patient underwent femoral nerve block : group A 20 ml ropivacaine 0,5 % 20 ml lidocaine 1 % ; group B 20 ml ropivacaine 0,5 % , 20 ml lidocaine 1 % 4 mg dexamethasone ; group C 20 ml ropivacaine 0,5 % , 20 ml lidocaine 1 % 8 mg dexamethasone . All group receive postoperative analgesia visual analog scale ( VAS ) 3 ( request ) , IV Perfalgan 1 g morphine ( load dose 0.1 mg/kg titration VAS 3 , follow subcutaneous ( SC ) administration 1/2 total load dose demand follow 24 hour ( h ) . Efficacy evaluate time interval perform block first analgesic dose require , total amount morphine first 24 h postoperative , patient satisfaction neurological side effect .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>ASA IIII BMI &lt; 40 High risk grade hypertension Chronic renal failure Known allergy drug use Chronic treatment steroid Drugs dependency History diabetes mellitus Ulcer chronic gastritis Infection puncture site Neuropathy surgical level Coagulopathy Requesting another type anesthesia Fear sign inform consent Bypass aortofemoral</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>